Literature DB >> 20453535

Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Jorge A Quiroz1, Rodrigo Machado-Vieira, Carlos A Zarate, Husseini K Manji.   

Abstract

The monovalent cation lithium partially exerts its effects by activating neurotrophic and neuroprotective cellular cascades. Here, we discuss the effects of lithium on oxidative stress, programmed cell death (apoptosis), inflammation, glial dysfunction, neurotrophic factor functioning, excitotoxicity, and mitochondrial stability. In particular, we review evidence demonstrating the action of lithium on cyclic adenosine monophosphate (cAMP)-mediated signal transduction, cAMP response element binding activation, increased expression of brain-derived neurotrophic factor, the phosphatidylinositide cascade, protein kinase C inhibition, glycogen synthase kinase 3 inhibition, and B-cell lymphoma 2 expression. Notably, we also review data from clinical studies demonstrating neurotrophic effects of lithium. We expect that a better understanding of the clinically relevant pathophysiological targets of lithium will lead to improved treatments for those who suffer from mood as well as neurodegenerative disorders. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453535      PMCID: PMC2889681          DOI: 10.1159/000314310

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  105 in total

1.  A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania.

Authors:  J M Bebchuk; C L Arfken; S Dolan-Manji; J Murphy; K Hasanat; H K Manji
Journal:  Arch Gen Psychiatry       Date:  2000-01

Review 2.  Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

Authors:  Todd D Gould; Carlos A Zarate; Husseini K Manji
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

3.  Social stress exacerbates stroke outcome by suppressing Bcl-2 expression.

Authors:  A C DeVries; H D Joh; O Bernard; K Hattori; P D Hurn; R J Traystman; N J Alkayed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.

Authors:  Frank Willmroth; Tobias Drieling; Ulrich Lamla; Michael Marcushen; Hans-Jörg Wark; Dietrich van Calker
Journal:  Int J Neuropsychopharmacol       Date:  2006-01-18       Impact factor: 5.176

5.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

Authors:  G J Moore; J M Bebchuk; K Hasanat; G Chen; N Seraji-Bozorgzad; I B Wilds; M W Faulk; S Koch; D A Glitz; L Jolkovsky; H K Manji
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

6.  Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures.

Authors:  M Yeste; D Alvira; E Verdaguer; M Tajes; J Folch; V Rimbau; M Pallàs; A Camins
Journal:  J Neural Transm (Vienna)       Date:  2006-08-17       Impact factor: 3.575

7.  Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

Authors:  Xiaohua Li; Kelley M Rosborough; Ari B Friedman; Wawa Zhu; Kevin A Roth
Journal:  Int J Neuropsychopharmacol       Date:  2006-05-04       Impact factor: 5.176

8.  Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.

Authors:  J K Rybakowski; A Suwalska; M Skibinska; A Szczepankiewicz; A Leszczynska-Rodziewicz; A Permoda; P M Czerski; J Hauser
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

9.  The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

Authors:  Haim Einat; Peixiong Yuan; Todd D Gould; Jianling Li; JianHua Du; Lei Zhang; Husseini K Manji; Guang Chen
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

10.  Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.

Authors:  Yuly Bersudsky; Alona Shaldubina; Nitzan Kozlovsky; James R Woodgett; Galila Agam; R H Belmaker
Journal:  Behav Pharmacol       Date:  2008-05       Impact factor: 2.293

View more
  58 in total

1.  Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.

Authors:  Ji-Woon Kim; Lisa M Monteggia
Journal:  Behav Brain Res       Date:  2019-11-21       Impact factor: 3.332

Review 2.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

Review 3.  Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  B K Kishore; N G Carlson; C M Ecelbarger; D E Kohan; C E Müller; R D Nelson; J Peti-Peterdi; Y Zhang
Journal:  Acta Physiol (Oxf)       Date:  2015-05-04       Impact factor: 6.311

4.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

Review 5.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.

Authors:  Michael J Berridge
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

6.  Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 cells: involvement of Akt and Nrf2/ARE pathways.

Authors:  Lan Wang; Rikang Wang; Minghua Jin; Yingjuan Huang; Anmin Liu; Jian Qin; Meihui Chen; Shijun Wen; Rongbiao Pi; Wei Shen
Journal:  Neurochem Res       Date:  2014-06-21       Impact factor: 3.996

7.  Lithium prevents REM sleep deprivation-induced impairments on memory consolidation.

Authors:  Simone M Ota; Karin Di Monteiro Moreira; Deborah Suchecki; Maria Gabriela M Oliveira; Paula A Tiba
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

Review 8.  Potential therapeutic uses of BDNF in neurological and psychiatric disorders.

Authors:  Alan H Nagahara; Mark H Tuszynski
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

Review 9.  Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.

Authors:  O V Forlenza; V J R De-Paula; B S O Diniz
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

10.  L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.

Authors:  Liting Luo; Jingkao Chen; Dan Su; Meihui Chen; Bingling Luo; Rongbiao Pi; Lan Wang; Wei Shen; Rikang Wang
Journal:  Neurochem Res       Date:  2017-01-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.